Senseonics Reports Strong Q1 Growth and Strategic Advances

Senseonics Holdings Inc. ( (SENS) ) has released its Q1 earnings. Here is a breakdown of the information Senseonics Holdings Inc. presented to its investors.

Senseonics Holdings, Inc. is a medical technology company specializing in the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for individuals with diabetes. The company’s innovative approach includes products like the Eversense 365, which offers extended glucose monitoring capabilities.

In its first-quarter financial results for 2025, Senseonics reported a revenue of $6.3 million, marking a 24% increase compared to the previous year. The company highlighted its strategic partnership with Sequel to integrate the twiist automated insulin delivery system with the Eversense 365 CGM, with a launch anticipated in the third quarter.

Key financial metrics revealed a significant improvement in gross profit, which rose to $1.5 million from $0.3 million in the same quarter of the previous year, driven by increased margins on the Eversense 365 product. Additionally, the company managed to reduce its net loss to $14.3 million, a decrease from $18.9 million in the first quarter of 2024, due to improved gross profit margins and reduced research and development expenses.

The company also achieved a major milestone with the CMS updating the 2025 physician fee schedule to provide reimbursement for a full year of usage with Eversense 365, effective retroactively for Medicare beneficiaries. Furthermore, Senseonics completed its CE Mark application for Eversense 365 in the European Union, with a launch expected in the latter half of 2025.

Looking ahead, Senseonics maintains a positive outlook for the full year 2025, expecting global net revenue to reach between $34-38 million as it continues to expand its patient base and roll out Eversense 365 in the U.S. The company anticipates increased gross margins and plans to leverage strategic partnerships and marketing initiatives to drive growth.